Company Overview and News

 
Musakhedi residents’ protest against ‘hiked’ power bills

2016-01-30 freepressjournal.in
Indore : Musakhedi residents staged a protest against the recently issued electricity bills, which total charges varying between Rs 10,000 to Rs 25,000. The protest was staged objecting to the hiked amount in the bills, which seem to be unreasonable based on the size of houses.

 
After Roti Bank, a ‘Kapda Bank’ opened in Maharashtra by Haron Mukati Islamic Centre

2016-01-26 financialexpress
After launching a 'Roti Bank' here last month, the Haron Mukati Islamic Centre on Tuesday inaugurated a 'Kapda Bank' intended to provides clothes to the poorest of poor.

 
Jubilant Biosys et Sanofi Deutschland GmbH concluent un accord stratégique pour lutter contre les troubles du métabolisme

2016-01-08 prnewswire
BANGALORE, January 8, 2016 /PRNewswire/ -- Cette collaboration vise à découvrir et développer...

 
2015 Year In Review: Debrief After Decline

2016-01-07 seekingalpha
Looking back is painful when stock market outcomes have gone awry. But the clarity of hindsight should be taken advantage of to improve future investing outcome

 
3 Buy-Rated Dividend Stocks Leading The Pack: NYCB, CCI, BPL

2016-01-06 thestreet
These 3 dividend stocks are rated a Buy by TheStreet

 
CONE Midstream Partners (CNNX) Upgraded to Strong Buy

2016-01-05 zacks
CONE Midstream Partners (CNNX) has been upgraded to a Zacks Rank #1 (Strong Buy).

 
10-Year Treasury and MLP Yields Have Converged

2016-01-04 marketrealist
The Alerian MLP ETF (AMLP) was trading at a yield of 9.8% at the end of the week ended January 1, 2016. The yield fell for the third straight week from 9.9% at the end of the previous week. AMLP tracks the Alerian MLP Infrastructure Index (or AMZI), a subset of the benchmark Alerian MLP Index (or AMZ). AMZ remained flat during the week.

 
PUTNAM HIGH YIELD TRUST Form 485BPOS

2015-12-29 sec.gov
a_hyt485b.htm As filed with the Securities and Exchange Commission on        December 28, 2015          Registration No. 2-60492    811-02796      SECURITIES AND EXCHANGE COMMISSION    WASHINGTON, D.C. 20549      ----------------      FORM N-1A    ----    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933  / X /  ----      ----  Pre-Effective Amendment No.  / /    ----    ----      Post-Effective Amendment No.

 
Midstream MLPs' Potential Funding Hurdles

2015-12-28 seekingalpha
TCStocks in Energy Master Limited Partnerships (MLPs) have experienced some of the worst declines of any sector this year. The below chart of the Credit Suisse X-Links Cushings MLP Infrastructure ETN

 
PUTNAM FUNDS TRUST Form 485BPOS

2015-12-24 sec.gov
a_pft485b.htm As filed with the Securities and Exchange Commission on       December 23, 2015         Registration No. 333-515    811-07513    SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   ---------------   FORM N-1A     ----    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933  / X /      ----      ----    Pre-Effective Amendment No.  / /      ----      ----          Post-Effective Amendment No.

 
Low Oil Prices Aren't The Only Thing That Should Worry MLP Investors

2015-12-24 seekingalpha
Majority of oil and gas demand in the US is driven by transportation.The transportation industry is poised for a once in several decades seismic shift in fuel economy.Higher fuel economy and correspon

 
MLPs mauled again as crude oil sinks below $35/bbl

2015-12-18 seekingalpha
Energy MLPs sustained more punishment today as crude oil prices tumbled below $35/bbl and credit rating agencies teed up more energy companies for possible downgrades; today's dividend cut from Teekay

 
MLPs mauled again as crude oil sinks below $35/bbl

2015-12-18 seekingalpha
Energy MLPs sustained more punishment today as crude oil prices tumbled below $35/bbl and credit rating agencies teed up more energy companies for possible downgrades; today's dividend cut from Teeka

 
MLPs mauled again as crude oil sinks below $35/bbl

2015-12-18 seekingalpha
Energy MLPs sustained more punishment today as crude oil prices tumbled below $35/bbl and credit rating agencies teed up more energy companies for possible downgrades; today's dividend cut from Teeka

 
Nustar Energy Form DEF 14A

2015-12-18 sec.gov
  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 14A (Rule 14a-101)   SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.    )   Filed by the Registrant       þ              Filed by a Party other than the Registrant               ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for use of the Commission only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy Stat

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...